Showing results (11-20 of 276) with videos related to

Sort By:
Pageof 28
In Vivo (Athens, Greece)|January 1, 2022
Extraperitoneal Approach During Peritonectomy in the Right Upper Quadrant for Peritoneal Metastases from Ovarian MalignanciesMiklos Acs, Hubert Leebmann, Sebastian Häusler, et al.
Onkologie|March 15, 2012
Treatment of elderly ovarian cancer patients in the context of controlled clinical trials: a joint analysis of the AGO Germany experienceFelix Hilpert, Pauline Wimberger, Andreas du Bois, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 24, 2017
Brief Report About the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer From Spiliotis et alPhilipp Harter, Alexander Reuss, Jalid Sehouli, et al.
Archives of Gynecology and Obstetrics|February 18, 2014
Implementation of robot-assisted gynecologic surgery for patients with low and high BMI in a German gynecological cancer centerPäivi Kannisto, Philipp Harter, Florian Heitz, et al.
Expert Review of Anticancer Therapy|July 11, 2009
Role of cytoreductive surgery in recurrent ovarian cancerPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
Expert Review of Anticancer Therapy|December 18, 2009
Systemic therapy in recurrent ovarian cancer: current treatment options and new drugsPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
Gynecologic Oncology|June 24, 2016
FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisitedBeyhan Ataseven, Luis M Chiva, Philipp Harter, et al.
Gynecologic Oncology Reports|February 16, 2022
Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experienceMalak Moubarak, Philipp Harter, Beyhan Ataseven, et al.
Therapeutic Advances in Medical Oncology|January 2, 2014
Current and future options in the management and treatment of uterine sarcomaKhalid El-Khalfaoui, Andreas du Bois, Florian Heitz, et al.
Expert Review of Anticancer Therapy|July 22, 2010
Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapyFlorian Heitz, Philipp Harter, Nina Ewald-Riegler, et al.
Pageof 28